Blood, antisera, vaccines, toxins and cultures in United States

EXPORTS (2018): $27.2B, World Rnk 4 / 171
Flag Rnk 7 / 1222

TOP DESTINATION (2018): $2.84B, Germany

FASTEST GROWING MARKET (2017 - 2018): $897M, Netherlands

IMPORTS (2018): $39B, World Rnk 1 / 214
Flag Rnk 9 / 1217

TOP ORIGIN (2018): $13.3B, Ireland

FASTEST GROWING ORIGIN (2017 - 2018): $3.61B, Switzerland

ECONOMIC COMPLEXITY of United States (2018): 1.57, Rnk 9 / 137

PRODUCT COMPLEXITY  IN Blood, antisera, vaccines, toxins and cultures (2018): 1.18, Rnk 110 / 1018

Exports: In 2018, United States exported $27.2B in Blood, antisera, vaccines, toxins and cultures, making it the 4th largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 7th most exported product in United States. The main destination of Blood, antisera, vaccines, toxins and cultures exports from United States are: Germany ($2.84B), Netherlands ($2.72B), Italy ($2.6B), Switzerland ($2.4B), and Belgium-Luxembourg ($2.12B).

The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of United States between 2017 and 2018 were Netherlands ($897M), Italy ($829M), and Belgium-Luxembourg ($661M).

Imports: In 2018, United States imported $39B in Blood, antisera, vaccines, toxins and cultures, becoming the 1st largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 9th most imported product in United States. United States imports Blood, antisera, vaccines, toxins and cultures primarily from: Ireland ($13.3B), Switzerland ($6.58B), Germany ($3.3B), United Kingdom ($3.04B), and Belgium-Luxembourg ($2.94B).

The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for United States between 2017 and 2018 were Switzerland ($3.61B), Ireland ($2.69B), and Singapore ($2.06B).

Overview: In October 2020 United States' Blood, antisera, vaccines, toxins and cultures exports accounted up to $2.49B and imports accounted up to $4.82B, resulting in a negative trade balance of $2.33B. Between October 2019 and October 2020 the exports of United States'   Blood, antisera, vaccines, toxins and cultures have increased by $35M (1.42%) from $2.46B to $2.49B, while imports increased by $1.03B (27.3%) from $3.79B to $4.82B.

Destinations: In October 2020 Blood, antisera, vaccines, toxins and cultures exported mostly to Netherlands ($444M), Germany ($355M), Switzerland ($198M), Italy ($196M), and Japan ($179M), and imported mostly from Ireland ($1.18B), Germany ($1.05B), Belgium ($885M), Switzerland ($394M), and Singapore ($235M).

Growth: In October 2020, the increase in Blood, antisera, vaccines, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to Netherlands ($167M or 60.1%), Switzerland ($114M or 136%), and Germany ($90.8M or 34.3%). In October 2020, the increase in Blood, antisera, vaccines, toxins and cultures's year-by-year imports was explained primarily by an increase in imports from Germany ($627M or 147%), Belgium ($561M or 173%), and Japan ($143M or 224%).

Subnational Monthly Trade

#permalink to section
Flow
Value

EXPORT GROWTH (October 2019 - October 2020): $35M, (1.42%)

IMPORT GROWTH (October 2019 - October 2020): $1.03B, (27.3%)

MAIN EXPORTER (October 2020): Puerto Rico, $406M

MAIN DESTINATION (October 2020): Netherlands, $444M

This section shows Blood, antisera, vaccines, toxins and cultures's exports and imports data at subnational level for United States. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Blood, antisera, vaccines, toxins and cultures over time.

Value

EXPORTS (2018): $27.2B

IMPORTS (2018): $39B

NET TRADE (2018): -$11.9B

In 2018, United States exported $27.2B in Blood, antisera, vaccines, toxins and cultures. The main destinations of United States exports on Blood, antisera, vaccines, toxins and cultures were Germany ($2.84B), Netherlands ($2.72B), Italy ($2.6B), Switzerland ($2.4B), and Belgium-Luxembourg ($2.12B).

In 2018, United States imported $39B in Blood, antisera, vaccines, toxins and cultures, mainly from Ireland ($13.3B), Switzerland ($6.58B), Germany ($3.3B), United Kingdom ($3.04B), and Belgium-Luxembourg ($2.94B).

Explore Visualizations

IN 2018, United States HAD A POSITIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

IN 2018, United States HAD A NEGATIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

Flow

THE FASTEST GROWING Blood, antisera, vaccines, toxins and cultures EXPORT MARKETS FOR United States WERE (2017 - 2018):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Blood, antisera, vaccines, toxins and cultures BY United States WERE (2017 - 2018):

Explore Visualizations

Market Concentration

#permalink to section
Flow
Type

In 2018, United States's main exporting competitors in Blood, antisera, vaccines, toxins and cultures were:

In 2018, United States's main importing competitors in Blood, antisera, vaccines, toxins and cultures were:

Explore Visualizations

Trade Forecasts

#permalink to section

Time

This section shows forecasts for total exports and imports, for Blood, antisera, vaccines, toxins and cultures in United States. The forecast is based on a short-term, medium-term and long-term model using yearly trade data.

Explore Forecasts

Tariffs by Country

#permalink to section

In 2017, the tariffs for Blood, antisera, vaccines, toxins and cultures in the imports of United States were of 0% around the world.

Explore Tariff Data